- Home
- AVD vs VIGL Comparison
AVD vs VIGL Comparison
Compare AVD & VIGL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- AVD
- VIGL
- Stock Information
- Founded
- AVD 1969
- VIGL 2020
- Country
- AVD United States
- VIGL United States
- Employees
- AVD N/A
- VIGL N/A
- Industry
- AVD Agricultural Chemicals
- VIGL Biotechnology: Pharmaceutical Preparations
- Sector
- AVD Industrials
- VIGL Health Care
- Exchange
- AVD Nasdaq
- VIGL Nasdaq
- Market Cap
- AVD 104.4M
- VIGL 134.9M
- IPO Year
- AVD N/A
- VIGL 2022
- Fundamental
- Price
- AVD $3.90
- VIGL $7.96
- Analyst Decision
- AVD Strong Buy
- VIGL Buy
- Analyst Count
- AVD 1
- VIGL 7
- Target Price
- AVD $12.00
- VIGL $8.00
- AVG Volume (30 Days)
- AVD 240.6K
- VIGL 1.5M
- Earning Date
- AVD 06-06-2025
- VIGL 08-12-2025
- Dividend Yield
- AVD N/A
- VIGL N/A
- EPS Growth
- AVD N/A
- VIGL N/A
- EPS
- AVD N/A
- VIGL N/A
- Revenue
- AVD $527,962,999.00
- VIGL N/A
- Revenue This Year
- AVD N/A
- VIGL N/A
- Revenue Next Year
- AVD $3.54
- VIGL N/A
- P/E Ratio
- AVD N/A
- VIGL N/A
- Revenue Growth
- AVD N/A
- VIGL N/A
- 52 Week Low
- AVD $3.28
- VIGL $1.31
- 52 Week High
- AVD $9.84
- VIGL $7.96
- Technical
- Relative Strength Index (RSI)
- AVD 44.29
- VIGL 88.44
- Support Level
- AVD $3.54
- VIGL $7.86
- Resistance Level
- AVD $4.08
- VIGL $7.90
- Average True Range (ATR)
- AVD 0.27
- VIGL 0.03
- MACD
- AVD -0.04
- VIGL -0.20
- Stochastic Oscillator
- AVD 30.00
- VIGL 91.67
About AVD American Vanguard Corporation ($0.10 Par Value)
American Vanguard Corp is a United States-based diversified specialty and agricultural products company. It manufactures and formulates chemicals for crops, turf and ornamental plants, and human and animal health protection. These chemicals include insecticides, fungicides, herbicides, molluscicides, growth regulators, and soil fumigants, which are marketed in liquid, powder, and granular forms.
About VIGL Vigil Neuroscience Inc.
Vigil Neuroscience Inc is a clinical-stage biotechnology company engaged in improving the lives of patients, caregivers, and families affected by rare and common neurodegenerative diseases by pursuing the development of disease-modifying therapeutics to restore the vigilance of microglia. Microglia are the sentinel immune cells of the brain and play a critical role in maintaining central nervous system (CNS) health and responding to damage caused by disease. The group provides solutions for fully human monoclonal antibody and Oral small molecule TERM2 agonist.